Loading clinical trials...

COVID-19 Endoscopy Survey | Clinical Trials | Clareo Health

COMPLETEDNCT04342637

COVID-19 Endoscopy Survey

A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and...

Lead sponsor: Al-Azhar University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Al-Azhar University

Participants has to answer the following questions: 1. Participating center data: * Participant name (surname, first name): (optional) * Participant email: (optional) * Country: …….. * Working days (before COVID-19): …….. * Types of procedure performed /day (before COVID-19): ……. * Number of endoscopists /day (before COVID-19): ……. * Number of nursing staff /day (before COVID-19): ……. * Number of administrative staff /day (before COVID-19): ……. * Number of patients undergoing endoscopy/ day (before COVID-19): ……. * Availability of negative pressure rooms (before COVID-19): ……. * Number of endoscopy referrals/ day (before COVID-19): …….. 2. Response to COVID-19: * Working days (after COVID-19): …….. * Types of procedure performed /day (after COVID-19): …….. * Number of endoscopists /day (after COVID-19): …….. * Number of nursing staff /day (after COVID-19): …….. * Number of administrative staff /day (after COVID-19): …….. * Do you consider teams (MD, RN, tech, anesthesia) that remain together for the entire day so as to compartmentalize and minimize personnel exposure? * Number of patients undergoing endoscopy/ day (after COVID-19): …….. * Number of endoscopy referrals/ day (after COVID-19): …….. * Availability of negative pressure rooms or use portable industrial-grade high-efficiency particulate air (HEPA) filters as a reasonable alternative: …….. * Which recommendations do you follow? WEO, AGA, BSG, APSDE, other * Applying triage for patients: e.g. FTOCC (APSDE); dose this include any tests * Do you use any of this for triage of patients: i) a telephone consultation with the referring provider or (ii) a telehealth visit with the patient or (iii) a multidisciplinary team approach or (virtual) disease/tumor board to facilitate decision-making for complicated patients. * Prioritization: Which classification do you use for endoscopic procedures? 1. urgent, semi-urgent and elective during COVID-19 outbreak 2. Time sensitive procedure: * Time-sensitive procedures defined as procedures that if deferred may negatively impact patient-important outcomes. The decision to defer a procedure should be made on a case-by-case basis: * Time-Sensitive\* (within 24 hours-8 weeks): 1. Threat to the patient's life or Permanent dysfunction of an organ e.g. diagnosis and treatment of GI bleeding or cholangitis 2. Risk of metastasis or progression of stage of disease e.g. e.g. work up of symptoms suggestive of cancer 3. Risk of rapidly worsening progression of disease or severity of symptoms e.g. management decisions, such as treatment for IBD * Non-Time Sensitive: No short-term impact on patient-important outcomes e.g. screening or surveillance colonoscopy, follow up colonoscopy for +FIT * What are the most common clinical presentations? (please choose all that apply): Upper GI bleeding, lower GI bleeding, cholangitis, suspected cancer, foreign body, relive of GI obstruction, gastrostomy, other 3. Endoscopy and use of PPE: * Did you receive appropriate education and training on infection control measures, including hand hygiene. * Did you receive adequate training on gowning and removal of PPE? * Do you practice Standard hand hygiene procedures before and after each case? * What type of personal protective equipment (PPE) do you usually use for doing an endoscopic procedure nowadays? (choose all that apply) Surgical mask N95 mask Isolation gown with water resistance Head cover Eye protection Face shield N95 protection in combination with face shield or surgical mask Other (please specify): …….. * Do you extend (over 8 hours) use of N95 masks? * Do you re-use of N95 masks? * Do you extend use (over 8 hours) any other equipment? : ….. * Do you re use any other equipment? ….. * If yes, please specify: …… If yes please specify: ….. * Do you use of double gloves? …… * What PPE do you use for the following cases (choose all that apply)? 1. Suspected cases of SARS-CoV-2 infection: Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify 2. Probable cases of SARS-CoV-2 infection: Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify 3. confirmed cases of SARS-CoV-2 infection: Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify 4. Post endoscopy: * Do you motion in your report the status of the patients (suspected, probable, confirmed case of SARS-CoV-2 infection? * Do you use standard endoscopic decontamination or anything extra? * Do you give time for sterilizing endoscopy room after each suspected or confirmed case of SARS-CoV-2 infection? How long? * Do you call back your patients 2 weeks after procedure to ask them about symptoms/ diagnosis of SARS-CoV-2 infection? * Did you report any endoscopy related SARS-CoV-2 infection in your center (anytime for HCWs \& up to two weeks after procedures for patients)? * Are you preparing a management plan for the waiting list after the current phase of the pandemic?

Related studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITINGPhase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213 · Adenovirus Infection, BK Virus Infection, and more

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more

RECRUITINGNA

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more

RECRUITINGNA

Long COVID Brain Fog: Cognitive Rehabilitation Trial

NCT06095297 · Long COVID, Brain Fog, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 20, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment163

Start dateApr 2020

Last updatedMay 20, 2020

Condition

COVID-19

Locations shown

Kings County Hospital Center, Brooklyn, NY, USA

Albertson, New York

Faculty of Medicine, Zagazig University

Zagazig, Sharqia Province

Al-Azhar Univerisity

Cairo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 20, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions